85952-29-0

Basic information

• Product Name: N-Methyl-1-(4-nitrophenyl)methanesulfonamide
• Synonyms: BENZENEMETHANESULFONAMIDE,N-METHYL-4-NITRO-;N-methyl-4-nitrotoluenesulphonamide;4-NITRO-N-METHTYL BENZENE METHANE SULFONAMIDE;4-Nitro-Methyl-Benzene-Methane-Sulfonamide;N-Methyl-4-nitro-ɑ-toluenesulfonamide, 98%;N-Methyl-4-nitro-^a-toluenesulfonamide, 98%;N-Methyl-4-nitro-alpha-toluenesulfonamide, 98%;N-Methyl-4-nitro-α-toluenesulfonamide
• CAS NO: 85952-29-0
• Molecular Formula: C₈H₁₀N₂O₄S
• Molecular Weight: 230.24
• Mol File: 85952-29-0.mol

Chemical Properties

• Melting Point: 151-153°C
• Boiling Point: 417.5 °C at 760 mmHg
• Flash Point: 206.3 °C
• Appearance: /
• Density: 1.404 g/cm³
• Vapor Pressure: 3.53E-07mmHg at 25°C
• Refractive Index: 1.579
• Storage Temp.: 2-8°C
• PKA: 10.69±0.40(Predicted)
• CAS DataBase Reference: N-Methyl-1-(4-nitrophenyl)methanesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-Methyl-1-(4-nitrophenyl)methanesulfonamide(85952-29-0)
• EPA Substance Registry System: N-Methyl-1-(4-nitrophenyl)methanesulfonamide(85952-29-0)

Safety Data

• Hazardous Substances Data: 85952-29-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
N-Methyl-1-(4-nitrophenyl)methanesulfonamide is used as a reagent in hydrogenation reactors for the synthesis of pharmaceutical compounds. Its role in these reactions is to promote the reduction of specific functional groups, which is essential for the production of desired drug molecules. This reagent is particularly valuable in the development of new medications and the improvement of existing ones, contributing to advancements in healthcare and medicine.

InChI:InChI=1/C8H10N2O4S/c1-9-15(13,14)6-7-2-4-8(5-3-7)10(11)12/h2-5,9H,6H2,1H3

Upstream product

• 74-89-5 methylamine 
• 4025-75-6 (4-nitrophenyl)methanesulfonyl chloride 
• 19299-41-3 N-methyl-1-phenylmethanesulfonamide 
• 1939-99-7 benzenesulfonyl chloride 
• 36639-50-6 Sodium 4-nitrobenzylsulphonate 

Downstream Products

• 197580-86-2 N-ethoxycarbonyl-N-methyl-4-nitrobenzenemethanesulphonamide 
• 109903-35-7 1-(4-aminophenyl)-N-methylmethanesulfonamide 
• 88918-84-7 4-Amino-N-methylbenzenemethanesulphonamide, hydrochloride 
• 765252-40-2 C₁₁H₁₆N₂O₄S 
• 264909-30-0 piperidine-2,3-dione-3-[4-[(N-methylaminosulfonyl)methyl]phenylhydrazone] 
• 110654-61-0 N-Methyl-N-{[methyl-(4-nitro-phenylmethanesulfonyl)-amino]-methyl}-C-(4-nitro-phenyl)-methanesulfonamide 
• 94514-75-7 3-Methyl-6-nitro-3,4-dihydro-1H-benzo[d][1,2]thiazine 2,2-dioxide 

Relevant articles and documents

INHIBITORS OF PROTEIN KINASES

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).

Inhibitors of protein kinases

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceutical compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.

INHIBITORS OF PROTEIN KINASES

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).

Piperazine, piperidine and tetrahydropyridine derivatives useful as 5-HT1 recepter agonists

A class of N-substituted piperazine, piperadine and tetrahyrdopyridine derivatives of formula (I), further substituted at the 4-position by an optionally substituted aryl-alkyl or heteroaryl-alkyl moiety, are selective agonists of 5-HT1 -like r